Open AccessImportance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease
Author(s) -
Asad Izziddin Dajani,
Ruwayda Dham,
Medhat Elsahhar,
S Subeih,
Salman Sheikh,
Ahmed M. A. Mansour,
G El-Ebeidi,
Sara A. Mohammed,
M El Horaibi,
A Al Gawli,
Abrar Alanzi,
Sai Gautham,
Ossama Ashraf Ahmed,
Adnan M. Abu Hammour,
Mohamed Ismail Nounou,
Hanan Al-Mardini
Publication year - 2006
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.27739
Subject(s) - omeprazole , medicine , helicobacter pylori , gastroenterology , clarithromycin , peptic , endoscopy , maintenance therapy , peptic ulcer , chemotherapy
The role of Helicobacter pylori (H. pylori) eradication in non-steroidal anti inflammatory drug (NSAID) users with peptic ulcer disease is controversial especially in countries with a high prevalence of the infection. Furthermore the value of low dose omeprazole for maintenance of remission is not yet known.